Home / Conferences and Events / Miami Thyroid Oncology Symposium

The 5th Annual Miami Thyroid Oncology Symposium will be held virtually on March 18th and 19th, 2022

The Miami Cancer Research Center remains alert and vigilant to the ongoing coronavirus (COVID-19) pandemic. The 5th Annual Miami Thyroid Oncology Symposium will take place on March 18th and 19th, 2022Miami Cancer Research Center expresses its gratitude to everyone who has demonstrated their support. Contact MTOSContact@gmail.com with any questions.

About the Symposium

We welcome you to the 5th Miami Thyroid Oncology Symposium to discuss the rapidly expanding science of "Molecular Theranostics". Our approach to thyroid nodules and thyroid cancer has expanded beyond conventional diagnostics and therapeutic interventions. A broad catalog of genomic and epigenomic markers associated with thyroid cancer is now available and is in clinical use. The risk stratification systems that are critical for initial surgical treatment and subsequent use of radioactive iodine treatment rely more and more on distinct molecular markers, and less on traditional parameters. Genomics with molecular pathology and molecular imaging reflect the true biologic nature of the different cancer types currently defined by conventional morphologic features, The tumor differentiation/de-differentiation and clinical behavior for each individual cancer are now being defined by molecular characteristics, in addition to standard histopathology.

The 2022 Miami Thyroid Oncology Symposium (MTOS) offers a platform for an in-depth discussion of the science of thyroid cancer diagnosis and treatment in this new paradigm. It is a unique scientific forum where practicing physicians learn how to adapt and incorporate the new diagnostic and treatment tools and techniques into their daily practice.

The symposium is a two-day program. The first day of the symposium on Friday, March 18th, 2022 will feature a workshop on Advances in Radioactive iodine (RAI) Theranostics, which will provide in-depth approaches for RAI-indifferent cancers. The plenary session on the second day of the symposium on Saturday, March 19th, 2022 is entitled Frontiers in Thyroid Oncology. This session brings together world-renowned experts presenting and discussing the state of the Art in thyroid cancer diagnosis and treatment.

The 2022 Miami Thyroid Oncology Symposium (MTOS) will be held in a virtual format due to the unsettling course of the COVID-19 pandemic. We are committed to upholding the high-quality symposium standards we have built in the prior years. We are indebted to our world-renowned faculty for taking part in this exciting new scientific platform. We also hope to expand our attendance by reaching a larger national and international audience via the virtual format.

Miami Thyroid Oncology Symposium is organized by the Miami Cancer Research Center (MCRC). Miami Cancer Research Center is a scientific and charitable organization that performs and supports cancer research, organizes educational events, and provides support for cancer care at institutional and individual levels. The mission of the MCRC is to take part in the global fight against cancer through research, education, and patient care support.

Dade County Medical Association (DCMA) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. DCMA designates this educational activity for a maximum 0f 16 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. Please note that CME’s will be awarded from DCMA

Symposium Sponsors